Health House International Limited engages in the distribution of medicinal cannabis products and other medical supplies in the United Kingdom and Australia.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.12|
|52 Week High||AU$0.09|
|52 Week Low||AU$0.28|
|1 Month Change||0%|
|3 Month Change||-17.86%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-50.00%|
Recent News & Updates
|HHI||AU Healthcare||AU Market|
Return vs Industry: Insufficient data to determine how HHI performed against the Australian Healthcare industry.
Return vs Market: Insufficient data to determine how HHI performed against the Australian Market.
Stable Share Price: HHI is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: HHI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Health House International Limited engages in the distribution of medicinal cannabis products and other medical supplies in the United Kingdom and Australia. The company was formerly known as Health House Holdings Limited and changed its name to Health House International Limited in March 2021. The company was incorporated in 2011 and is based in Perth, Australia.
Health House International Fundamentals Summary
|HHI fundamental statistics|
Is HHI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HHI income statement (TTM)|
|Cost of Revenue||AU$6.68m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.03|
|Net Profit Margin||-62.41%|
How did HHI perform over the long term?See historical performance and comparison
Is Health House International undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate HHI's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate HHI's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: HHI is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.
PE vs Market: HHI is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HHI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HHI is overvalued based on its PB Ratio (3x) compared to the AU Healthcare industry average (2.1x).
How is Health House International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Health House International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Health House International performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: HHI is currently unprofitable.
Growing Profit Margin: HHI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if HHI's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare HHI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HHI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (61.3%).
Return on Equity
High ROE: HHI has a negative Return on Equity (-78.16%), as it is currently unprofitable.
How is Health House International's financial position?
Financial Position Analysis
Short Term Liabilities: HHI's short term assets (A$6.8M) exceed its short term liabilities (A$2.3M).
Long Term Liabilities: HHI's short term assets (A$6.8M) exceed its long term liabilities (A$911.7K).
Debt to Equity History and Analysis
Debt Level: HHI's debt to equity ratio (12.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if HHI's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: HHI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if HHI's interest payments on its debt are well covered by EBIT.
What is Health House International current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HHI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HHI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HHI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HHI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HHI's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
David Wheeler (63 yo)
Mr. David Colin Wheeler, FAICD, BA (Bus), SDIA, serves as Non-Executive Director of Athena Resources Limited since June 30, 2021. He serves as Non-Executive Director of Cradle Resources Limited since Octob...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD89.07K) is below average for companies of similar size in the Australian market ($USD302.72K).
Compensation vs Earnings: Insufficient data to compare David's compensation with company performance.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.
Health House International Limited's employee growth, exchange listings and data sources
- Name: Health House International Limited
- Ticker: HHI
- Exchange: ASX
- Founded: 2011
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: AU$20.392m
- Shares outstanding: 177.32m
- Website: https://healthhouse.com.au
- Health House International Limited
- 101 St Georges Terrace
- Level 3
- Western Australia
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/17 07:04|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.